Lung cancer — all decisions

The Board denied the appellant's claim for an earlier effective date for DIC benefits, finding that the correct effective date was June 9, 1999.

The Board found no evidence to support service connection for the cause of death, as lung cancer was not shown to be related to service. The veteran's death is attributed to cardiopulmonary arrest due to metastatic lung cancer.

The Board denied service connection for the cause of the veteran's death, concluding that there was no clear and unmistakable error in their decision.

The veteran's lung cancer, status post left upper segmenectomy, emphysema and COPD were not incurred during service or related to active duty service. The Board denied the claim for service connection.

The Board found no new and material evidence to reopen the claim of service connection for the cause of the veteran's death, resulting in a denial. The appellant's daughter testified that the veteran may have had a stroke or his service-connected conditions might have contributed to his death, but these were not supported by medical evidence.

The Board denied the appellant's claim of service connection for cause of death, finding that there is no evidence showing a relationship between the veteran's lung cancer and his military service.

The October 2005 Board decision denied service connection for lung cancer due to lack of new and material evidence. The veteran's appeal was not timely filed.

The Board found no evidence that the lung cancer causing the veteran's death was related to his military service or any of his service-connected conditions.

The Board found that there is no medical evidence linking the veteran's lung cancer to his service, including exposure to herbicides. The Board also noted that the disease was not linked to a service-connected disability. Therefore, the cause of death was denied.

The Board has remanded the case due to uncertainty regarding the veteran's exposure to asbestos during service, and a request for clarification is needed from the Navy Medical Liaison office at the National Personnel Records Center (NPRC).

The Board found that the veteran's cause of death (lung cancer and bronchial asthma) was not caused or contributed substantially to by any service-connected disability. The appellant did not meet the requirements for nonservice-connected death pension benefits, nor did she timely file her claim within one year after the veteran's death.

The veteran's appeal is remanded due to the need for a new VA examination and potential consideration of recent amendments to the VA Schedule for Rating Disabilities concerning respiratory conditions.

The Board denied service connection for the cause of the veteran's death due to his nicotine dependence, which led to COPD and other conditions that contributed to his death. The appellant is therefore not eligible for DIC benefits.

The Board denied the appellant's claims for service connection for the cause of the veteran's death and accrued benefits due to a lack of evidence linking any current conditions to military service.

The Board found that the veteran's lung cancer was not related to service and denied DIC benefits.

The veteran's lung cancer is granted service connection, presumed due to exposure to Agent Orange during his military service.

The Board has determined that the veteran's lung cancer, which he was diagnosed with in February 1998 and linked to his asbestos exposure during service, meets the criteria for service connection for accrued benefits purposes.

The Board denied the appellant's claim for service connection for the cause of her husband's death, finding no evidence linking his lung cancer to his military service or exposure to herbicides.

The Board has remanded the case due to incomplete evidence and a need for further medical opinion. The appellant's claim of service connection for the cause of her husband's death is pending.

The Board found that the primary cause of death was renal cell carcinoma, not lung cancer. The veteran's service connection for lung cancer is denied due to lack of evidence showing a primary site in the lungs.